Aurobindo Pharma Announcements
Submission of clarification with reference to movement of volume.
30 Oct, 2025 | 03:23pm • Source: BSE
The Exchange has sought clarification from Aurobindo Pharma Ltd on October 30, 2025, with reference to Movement in Volume. <BR><BR>The reply is awaited.
30 Oct, 2025 | 02:41pm • Source: BSE
Aurobindo Pharma Limited has informed the Exchange about Schedule of meet
28 Oct, 2025 | 10:53am • Source: NSE
Intimation of plant visit by investor group.
28 Oct, 2025 | 10:39am • Source: BSE
Intimation of the date of Earnings Call on Unaudited Financial Results of the Company for the second quarter and half year ended 30.09.2025.
28 Oct, 2025 | 10:36am • Source: BSE
Aurobindo Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2025 ,inter alia, to consider and...
24 Oct, 2025 | 04:05pm • Source: BSE
Aurobindo Pharma Limited has informed the Exchange about Incorporation of a step down subsidiary in Chile viz Eugia Pharma Chile SpA
23 Oct, 2025 | 10:31am • Source: NSE
Aurobindo Pharma Limited has informed the Exchange about Incorporation of a step down subsidiary viz Aurobindo Pharma Chile SpA
23 Oct, 2025 | 10:29am • Source: NSE
Submission of notice published in newspapers regarding relodgement of transfer requests of physical shares.
16 Oct, 2025 | 12:51pm • Source: BSE
Submission of certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
07 Oct, 2025 | 06:20pm • Source: BSE
Intimation of resignation of Mr. S. Venkatesh Kumar as Associate Vice President, Engineering Purchases.
01 Oct, 2025 | 12:19pm • Source: BSE
Intimation of completion of transfer of shares among subsidiary companies.
01 Oct, 2025 | 12:00pm • Source: BSE
Intimation of incorporation of CuraTeQ Biologics (Malta) Limited, a new wholly owned stepdown subsidiary.
26 Sep, 2025 | 06:14pm • Source: BSE
Update on transfer of shares among subsidiary companies.
26 Sep, 2025 | 05:30pm • Source: BSE
Update on acquistion of 26% stake in Swarnaakshu Solar Power Private Limited.
26 Sep, 2025 | 03:54pm • Source: BSE
Intimation of closure of trading window.
24 Sep, 2025 | 12:32pm • Source: BSE
Aurobindo Pharma Limited has informed the Exchange about fire accident at Unit-IV of APL Healthcare Limited, a WOS of the Company
19 Sep, 2025 | 01:33pm • Source: NSE
Intimation of fire accident at Unit 4 of APL Healthcare Limited, a wholly owned subsidiary of the Company.
19 Sep, 2025 | 01:24pm • Source: BSE
Aurobindo Pharma Limited has informed the Exchange about completion Phase 3 Clinical Study for Denosumab Biosimilar vy CuaTeQ Biologics
19 Sep, 2025 | 10:24am • Source: NSE